Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1976 3
1978 2
1979 1
1980 4
1981 6
1982 2
1983 3
1984 1
1985 4
1986 5
1987 3
1988 4
1989 3
1990 1
1991 5
1992 6
1993 7
1994 3
1995 3
1996 5
1997 6
1998 7
2000 7
2001 4
2002 7
2003 2
2004 2
2005 7
2006 3
2007 1
2008 6
2009 3
2010 7
2011 4
2012 5
2013 7
2014 9
2015 11
2016 12
2017 9
2018 7
2019 5
2020 13
2021 11
2022 7
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

228 results

Results by year

Filters applied: . Clear all
Page 1
Revision of ICH S8 Needed?
Van Der Laan JW. Van Der Laan JW. Front Toxicol. 2022 Apr 25;4:866737. doi: 10.3389/ftox.2022.866737. eCollection 2022. Front Toxicol. 2022. PMID: 35548682 Free PMC article. No abstract available.
Is current risk assessment of non-genotoxic carcinogens protective?
Braakhuis HM, Slob W, Olthof ED, Wolterink G, Zwart EP, Gremmer ER, Rorije E, van Benthem J, Woutersen R, van der Laan JW, Luijten M. Braakhuis HM, et al. Among authors: van der laan jw. Crit Rev Toxicol. 2018 Jul;48(6):500-511. doi: 10.1080/10408444.2018.1458818. Epub 2018 May 10. Crit Rev Toxicol. 2018. PMID: 29745287 Review.
Animal models in influenza vaccine testing.
van der Laan JW, Herberts C, Lambkin-Williams R, Boyers A, Mann AJ, Oxford J. van der Laan JW, et al. Expert Rev Vaccines. 2008 Aug;7(6):783-93. doi: 10.1586/14760584.7.6.783. Expert Rev Vaccines. 2008. PMID: 18665776 Review.
Oseltamivir and breastfeeding.
Wentges-van Holthe N, van Eijkeren M, van der Laan JW. Wentges-van Holthe N, et al. Among authors: van der laan jw. Int J Infect Dis. 2008 Jul;12(4):451. doi: 10.1016/j.ijid.2007.11.009. Epub 2008 Feb 1. Int J Infect Dis. 2008. PMID: 18243025 Free article. No abstract available.
Challenges and approaches for the development of safer immunomodulatory biologics.
Sathish JG, Sethu S, Bielsky MC, de Haan L, French NS, Govindappa K, Green J, Griffiths CE, Holgate S, Jones D, Kimber I, Moggs J, Naisbitt DJ, Pirmohamed M, Reichmann G, Sims J, Subramanyam M, Todd MD, Van Der Laan JW, Weaver RJ, Park BK. Sathish JG, et al. Among authors: van der laan jw. Nat Rev Drug Discov. 2013 Apr;12(4):306-24. doi: 10.1038/nrd3974. Nat Rev Drug Discov. 2013. PMID: 23535934 Free PMC article. Review.
Assessing immunotoxicity: guidelines.
Putman E, van der Laan JW, van Loveren H. Putman E, et al. Among authors: van der laan jw. Fundam Clin Pharmacol. 2003 Oct;17(5):615-26. doi: 10.1046/j.1472-8206.2003.00181.x. Fundam Clin Pharmacol. 2003. PMID: 14703723 Review.
Towards a mechanism-based approach for the prediction of nongenotoxic carcinogenic potential of agrochemicals.
Heusinkveld H, Braakhuis H, Gommans R, Botham P, Corvaro M, van der Laan JW, Lewis D, Madia F, Manou I, Schorsch F, Wolterink G, Woutersen R, Corvi R, Mehta J, Luijten M. Heusinkveld H, et al. Among authors: van der laan jw. Crit Rev Toxicol. 2020 Oct;50(9):725-739. doi: 10.1080/10408444.2020.1841732. Epub 2020 Nov 25. Crit Rev Toxicol. 2020. PMID: 33236972 Review.
Tumorigenicity assessment of cell therapy products: The need for global consensus and points to consider.
Sato Y, Bando H, Di Piazza M, Gowing G, Herberts C, Jackman S, Leoni G, Libertini S, MacLachlan T, McBlane JW, Pereira Mouriès L, Sharpe M, Shingleton W, Surmacz-Cordle B, Yamamoto K, van der Laan JW. Sato Y, et al. Among authors: van der laan jw. Cytotherapy. 2019 Nov;21(11):1095-1111. doi: 10.1016/j.jcyt.2019.10.001. Epub 2019 Nov 9. Cytotherapy. 2019. PMID: 31711733 Free article. Review.
Nonclinical regulatory immunotoxicity testing of nanomedicinal products: Proposed strategy and possible pitfalls.
Giannakou C, Park MVDZ, Bosselaers IEM, de Jong WH, van der Laan JW, van Loveren H, Vandebriel RJ, Geertsma RE. Giannakou C, et al. Among authors: van der laan jw. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Sep;12(5):e1633. doi: 10.1002/wnan.1633. Epub 2020 Apr 7. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020. PMID: 32266791 Free PMC article. Review.
228 results